Chromosomal Location and Identification of TBX20 as a New Gene Responsible for Familial Bicuspid Aortic Valve
Open Access
- 1 March 2025
- journal article
- research article
- Published by MDPI AG in Diagnostics
- Vol. 15 (5) , 600
Abstract
Background/Objectives: Congenital bicuspid aortic valve (BAV) signifies the most frequent category of congenital cardiovascular anomaly globally, occurring in approximately 0.5–2% of the general population worldwide. BAV is a major cause of thoracic aortopathy, encompassing aortic stenosis, aortic root dilation with regurgitation, aortic dissection, and aortic aneurysms, consequently leading to substantial late-onset morbidity and mortality. Accumulating evidence convincingly demonstrates the strong genetic basis underpinning BAV, though the inheritable reasons responsible for BAV in most patients remain largely obscure. Methods: A genome-wide genotyping with 400 polymorphic genetic markers followed by linkage analysis, haplotype assay, and sequencing analysis of candidate genes was conducted in a 4-generation BAV kindred of 47 individuals. Biochemical assays were performed to evaluate the functional effect of the identified mutation on TBX20. Results: A novel BAV-causative locus was mapped to chromosome 7p14. A sequencing assay of the genes within the mapped chromosomal region (locus) unveiled that only the c.656T>G (p.Ile219Arg) variation of TBX20 was in co-segregation with BAV in the entire pedigree. The missense mutation was not uncovered in 322 healthy persons employed as control individuals. Functional deciphers revealed that the mutation significantly decreased the transcriptional activation of the representative target gene ANP and the binding ability to the ANP promoter and impaired the intranuclear distribution of TBX20. Conclusions: This investigation maps a new genetic locus (chromosome 7p14) linked to BAV and uncovers TBX20 as a novel causative gene for familial BAV, adding more insight into the mechanisms underlying BAV and providing a molecular target for the individualized management of BAV.Keywords
All Related Versions
Funding Information
- Science and Technology Innovation Action Star Project of Shanghai, China (22YF1443000, 81641014, 20JC1418800)
- National Natural Science Foundation of China (22YF1443000, 81641014, 20JC1418800)
- Basic Research Project of Shanghai, China (22YF1443000, 81641014, 20JC1418800)
This publication has 74 references indexed in Scilit:
- Exploring genetic mapping and co-expression patterns to illuminate significance of Tbx20 in cardiac biologyTransgenic Research, 2025
- Whole-exome sequencing uncovers the genetic complexity of bicuspid aortic valve in families with early-onset complicationsThe American Journal of Human Genetics, 2024
- Exome copy number variant detection, analysis, and classification in a large cohort of families with undiagnosed rare genetic diseaseThe American Journal of Human Genetics, 2024
- De novo variants in DENND5B cause a neurodevelopmental disorderThe American Journal of Human Genetics, 2024
- Genetic and functional variants of the TBX20 gene promoter in dilated cardiomyopathyMolecular Genetics & Genomic Medicine, 2024
- Novel Association of the NOTCH Pathway Regulator MIB1 Gene With the Development of Bicuspid Aortic ValveJAMA Cardiology, 2023
- The role of the bicuspid aortic valve in sudden cardiac death–findings at cardiac autopsyCardiovascular Pathology, 2023
- GATA4 Loss-of-Function Mutation and the Congenitally Bicuspid Aortic ValveThe American Journal of Cardiology, 2018
- A Novel NKX2.5 Loss-of-Function Mutation Associated With Congenital Bicuspid Aortic ValveThe American Journal of Cardiology, 2014
- Characterization of the Human TBX20 Gene, a New Member of the T-Box Gene Family Closely Related to the Drosophila H15 GeneGenomics, 2000